TVARDI THERAPEUTICS, INC. Share-based Payment Arrangement, Expense
TVARDI THERAPEUTICS, INC. (TVRD) reported Share-based Payment Arrangement, Expense of $335.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $335.00K, a 46.57% decline year-over-year.
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $370.00K, a 362.50% increase year-over-year.
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $353.00K, a 346.84% increase year-over-year.
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $339.00K, a 323.75% increase year-over-year.
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2025 was $1.40M, a 338.56% increase from fiscal 2024.
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2024 was $319.00K.
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2019 was $10.30M, a 22.60% increase from fiscal 2018.
- TVARDI THERAPEUTICS, INC. share-based payment arrangement, expense for fiscal 2018 was $8.40M, a 32.72% increase from fiscal 2017.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $335.00K 10-Q · filed 2026-08-14 | $705.00K 10-Q · filed 2026-08-14 | $1.06M derived: sum of 3 quarters · filed 2026-08-14 | $1.40M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $370.00K 10-Q · filed 2026-05-08 | $723.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.06M derived: sum of 3 quarters · filed 2026-05-08 | $1.69M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $692.00K derived: sum of 2 quarters · filed 2026-03-31 | $1.32M derived: sum of 3 quarters · filed 2026-08-14 | $1.40M 10-K · filed 2026-03-31 |
| 2025-09-30 | $339.00K 10-Q · filed 2025-11-13 | $966.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.05M 10-Q · filed 2025-11-13 | $1.13M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $627.00K 10-Q · filed 2026-08-14 | $707.00K 10-Q · filed 2026-08-14 | $786.00K derived: sum of 3 quarters · filed 2026-08-14 | $866.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $80.00K 10-Q · filed 2026-05-08 | $159.00K derived: sum of 2 quarters · filed 2026-05-08 | $239.00K derived: sum of 3 quarters · filed 2026-05-08 | $318.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $159.00K derived: sum of 2 quarters · filed 2026-03-31 | $238.00K derived: sum of 3 quarters · filed 2026-03-31 | $319.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $80.00K 10-Q · filed 2025-11-13 | $159.00K derived: sum of 2 quarters · filed 2025-11-13 | $240.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $79.00K 10-Q · filed 2025-08-14 | $160.00K 10-Q · filed 2025-08-14 | ||
| 2021-06-30 | $3.03M 10-Q · filed 2021-08-09 | $5.63M 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | $2.60M 10-Q · filed 2021-05-10 | |||
| 2020-09-30 | $3.03M 10-Q · filed 2020-11-09 | $5.84M derived: sum of 2 quarters · filed 2021-08-09 | $8.52M 10-Q · filed 2020-11-09 | $11.19M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-06-30 | $2.81M 10-Q · filed 2021-08-09 | $5.49M 10-Q · filed 2021-08-09 | $8.16M derived: sum of 3 quarters · filed 2021-08-09 | $10.88M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $2.68M 10-Q · filed 2021-05-10 | $5.35M derived: sum of 2 quarters · filed 2021-05-10 | $8.06M derived: sum of 3 quarters · filed 2021-05-10 | $10.74M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.38M derived: sum of 2 quarters · filed 2020-11-09 | $8.07M derived: sum of 3 quarters · filed 2020-11-09 | $10.30M 10-K · filed 2020-02-27 |
| 2019-09-30 | $2.71M 10-Q · filed 2020-11-09 | $5.39M derived: sum of 2 quarters · filed 2020-11-09 | $7.63M 10-Q · filed 2020-11-09 | $10.27M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $2.68M 10-Q · filed 2020-08-10 | $4.92M 10-Q · filed 2020-08-10 | $7.56M derived: sum of 3 quarters · filed 2020-08-10 | $9.38M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $2.23M 10-Q · filed 2020-05-11 | $4.88M derived: sum of 2 quarters · filed 2020-05-11 | $6.70M derived: sum of 3 quarters · filed 2020-05-11 | $8.76M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $4.46M derived: sum of 2 quarters · filed 2020-02-27 | $6.53M derived: sum of 3 quarters · filed 2020-02-27 | $8.40M 10-K · filed 2020-02-27 |
| 2018-09-30 | $1.82M 10-Q · filed 2019-11-05 | $3.89M derived: sum of 2 quarters · filed 2019-11-05 | $5.76M 10-Q · filed 2019-11-05 | $7.57M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $2.07M 10-Q · filed 2019-08-07 | $3.94M 10-Q · filed 2019-08-07 | $5.75M derived: sum of 3 quarters · filed 2020-02-27 | $7.84M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $1.87M 10-Q · filed 2019-05-07 | $3.68M derived: sum of 2 quarters · filed 2020-02-27 | $5.78M derived: sum of 3 quarters · filed 2020-02-27 | |
| 2017-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $3.90M derived: sum of 2 quarters · filed 2020-02-27 | $6.33M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $2.09M 10-Q · filed 2018-11-06 | $4.52M 10-Q · filed 2018-11-06 | ||
| 2016-12-31 | $2.80M 10-K · filed 2019-03-12 | |||
| 2014-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $562.00K derived: sum of 2 quarters · filed 2015-03-27 | $1.02M derived: sum of 3 quarters · filed 2015-03-27 | $1.37M 10-K · filed 2015-03-27 |
| 2014-09-30 | $222.00K 10-Q · filed 2014-11-10 | $678.00K derived: sum of 2 quarters · filed 2014-11-10 | $1.03M 10-Q · filed 2014-11-10 | $1.04M derived: sum of 4 quarters · filed 2015-03-27 |
| 2014-06-30 | $456.00K 10-Q · filed 2014-08-07 | $809.00K 10-Q · filed 2014-08-07 | $822.00K derived: sum of 3 quarters · filed 2015-03-27 | $881.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2014-03-31 | $353.00K derived: 10-K 12 month − 3 quarters · filed 2015-03-27 | $366.00K derived: sum of 2 quarters · filed 2015-03-27 | $425.00K derived: sum of 3 quarters · filed 2015-03-27 | $465.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $72.00K derived: sum of 2 quarters · filed 2015-03-27 | $112.00K derived: sum of 3 quarters · filed 2015-03-27 | $123.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $59.00K 10-Q · filed 2014-11-10 | $99.00K derived: sum of 2 quarters · filed 2014-11-10 | $110.00K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $40.00K 10-Q · filed 2014-08-07 | $51.00K 10-Q · filed 2014-08-07 | ||
| 2012-12-31 | $61.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |